Filing Details
- Accession Number:
- 0001104659-20-101370
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-01 16:05:32
- Reporting Period:
- 2020-08-31
- Accepted Time:
- 2020-09-01 16:05:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1649904 | Rhythm Pharmaceuticals Inc. | RYTM | Pharmaceutical Preparations (2834) | 462159271 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1714105 | Nithya Desikan | 222 Berkeley Street, 12Th Floor Boston MA 02116 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-08-31 | 25,000 | $6.88 | 68,602 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-08-31 | 25,000 | $30.00 | 43,602 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2020-08-31 | 25,000 | $0.00 | 25,000 | $6.88 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
97,961 | 2027-08-08 | No | 4 | M | Direct |
Footnotes
- On August 31, 2020, Ms. Desikan exercised and sold 25,000 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- The stock options were granted on August 9, 2017. 32,715 of the total shares vested and became exercisable immediately upon grant. 25% of the remaining stock options vested and became exercisable on July 23, 2018. 75% of the remaining stock options shall vest in 36 successive, equal monthly installments with the first such installment vesting and becoming exercisable on August 23, 2018.